Sen-Jam Pharmaceutical Opens Enrollment For Patients In Their COVID Therapy Phase 2 Clinical Trial In Nepal And Engages With Strategic Investor For Worldwide Distribution'

Press/Media

Period6 May 2022

Media coverage

11

Media coverage